CN1279975A - Medicine for curing stomatocase - Google Patents

Medicine for curing stomatocase Download PDF

Info

Publication number
CN1279975A
CN1279975A CN 00111204 CN00111204A CN1279975A CN 1279975 A CN1279975 A CN 1279975A CN 00111204 CN00111204 CN 00111204 CN 00111204 A CN00111204 A CN 00111204A CN 1279975 A CN1279975 A CN 1279975A
Authority
CN
China
Prior art keywords
medicine
treatment
oral ulcer
cortex phellodendri
borneolum syntheticum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 00111204
Other languages
Chinese (zh)
Other versions
CN1119159C (en
Inventor
刘文功
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00111204A priority Critical patent/CN1119159C/en
Publication of CN1279975A publication Critical patent/CN1279975A/en
Application granted granted Critical
Publication of CN1119159C publication Critical patent/CN1119159C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A Chinese proprietary medicine consists of mixed fine powder of borneol 50-60 portions, catechu 10-20 portions, menthol 10-15 portions, borax 10-20 portions, Cortex Phellodendri 10-25 portions and natural indigo 10-15 portions. It has obvious curative effect on stomatocace and no toxic side-effect.

Description

A kind of medicine for the treatment of oral ulcer
The present invention relates to the Chinese herbal medicine is the Chinese patent medicine of raw material treatment oral ulcer.
In the human oral cavity in case suffer from illness such as aphtha, dispute are festered, flat the tinea in oral cavity, stomatitis, thrush, red whitish aphthae, just outbreak repeatedly, serious time by time, and cause the multiple complications of diet difficulty and human body, directly influence patient's body health.At present, to the treatment of oral ulcer, mainly contain following several method:
1, western medicine selects for use penicillin, streptomycin injection to come controlling symptoms clinically usually, but is difficult to radical cure, minority is more arranged to the penicillin and streptomycin allergy sufferers, can't use penicillin, streptomycin injection treatment;
2, Chinese patent drugs for treatment, the most frequently used Chinese patent medicine are the GUILIN XIGUA SHUANG that Sanjin Pharmaceutical Group Co, Guilin produces, and select for use watermelon crystal, Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendri, Bulbus Fritillariae Uninbracteatae, Fructus Sapindi Mukouossi, root of subprostrate sophora, borneol to be prepared from, and its deficiency is that curative effect is low; Number of patent application is 97103933 recovering liquid for oral cavity ulcer, be to be prepared from by Chinese herbal medicine such as Sanguis Draxonis, Borneolum Syntheticum, Borax, Margarita, Alumen, ERCHA, Myrrhas, Sanguis Draxonis in this medicine is that monarch drug, Myrrha are messenger drug, should be to be used for treating traumatic injury, fracture, have blood-activating analgetic, hemostatic effect, treat oral ulcer with Sanguis Draxonis, belong to the medication of not suiting the medicine to the illness, since monarch drug is not suited the medicine to the illness, how no matter ministerial drug dispose so, and its therapeutic effect just can not got well yet; Number of patent application is 97118982 the oral ulcer ointment of having a toothache, it is by Cinnabaris, Borax, Rhizoma Coptidis, Radix Et Rhizoma Rhei, Cortex Phellodendri, Radix Glycyrrhizae, Borneolum Syntheticum, beeswax, Oleum sesami is formulated, in this medicine, Cinnabaris, Borax is a monarch drug, the main tranquillizing and allaying excitement that rises, the antidotal effect, and oral ulcer is the table disease that the interior-heat by human body causes, treatment should be shown originally to take into account and just optimum curative effect can be obtained, Rhizoma Coptidis, Radix Et Rhizoma Rhei, Cortex Phellodendri is a ministerial drug, ministerial drug has heat clearing and damp drying under assistant monarch's effect, eliminating fire and detoxication, the effect of blood circulation promoting and blood stasis dispelling, because oral ulcer is to go up the fire of gas, and this ministerial drug is the fire of gas in rushing down, and pretends with little Radix Glycyrrhizae, Borneolum Syntheticum is an adjuvant drug, be dosage medication routinely, pain relieving is slow.From the above mentioned, select the Chinese patent drugs for treatment oral ulcer for use, DeGrain, curative effect is low.
The medicine that the purpose of this invention is to provide a kind of treatment oral ulcer evident in efficacy.
The medicine of this treatment oral ulcer is become by the following components by weight parts numeral system:
Borneolum Syntheticum 50-60 catechu 10-20
Herba Menthae 10-15 Borax 10-20
Cortex Phellodendri 10-25 Indigo Naturalis 10-15.
The medicine for preparing this treatment oral ulcer, the preferred weight umber scope of each component is:
Borneolum Syntheticum 50-55 catechu 10-18
Herba Menthae 10-12 Borax 10-15
Cortex Phellodendri 10-20 Indigo Naturalis 10-12.
The medicine for preparing this treatment oral ulcer, the optimum weight umber of each component is:
Borneolum Syntheticum 50 catechu 10
Herba Menthae 10 Boraxs 10
Cortex Phellodendri 10 Indigo Naturaliss 10.
The preparation method of the medicine of this treatment oral ulcer is:
A, respectively with decontamination, and through in the shady and cool ventilation environment withering catechu, Herba Menthae, Borax and Cortex Phellodendri powder be broken into the fine powder of granularity more than 80 orders, according to catechu, Herba Menthae, Borax and the Cortex Phellodendri parts by weight in this medicine, get catechu fine powder, Herba Menthae fine powder, Borax fine powder and Cortex Phellodendri fine powder, behind the mix homogeneously, make mixing fine powders, again under 100 ° ± 2 ℃ temperature, with mixing fine powders sterilization treatment 30-35 minute;
B, earlier respectively Borneolum Syntheticum, Indigo Naturalis are ground into the fine powder of granularity more than 80 orders, again under-10 °-15 ℃ temperature respectively with this two kinds of fine powder sterilization treatment 40-45 minute;
C, according to Borneolum Syntheticum, the parts by weight of Indigo Naturalis in this medicine, Borneolum Syntheticum fine powder after the sterilization treatment of learning from else's experience and Indigo Naturalis fine powder, the mixing fine powders mix homogeneously with after sterilization treatment makes medicine of the present invention, and is stored in dry ventilating and cooling place.
The medicine of treatment oral ulcer of the present invention, be based on secret prescription handed down in the family from generation to generation, according to understanding and the Therapeutic Principle of Chinese medicine to oral ulcer disease mechanism, with reference to the modern medicines achievement in research, from the Chinese medicine treasure-house, filter out heat-clearing and toxic substances removing, circulation of qi promoting dissipating blood stasis, evacuate hot blast, heat clearing away convergence, pathogenic fire purging poison, hold back skin ulcer, hemostasis, analgesic Chinese herbal medicine, press the theory of Chinese medical science compatibility, thereby this medicine is given full play to sterilized the effect of the generation of relieving inflammation or internal heat, relieving the pain bitterly, quickening wound healing, stop and issuing licence.According to theory of Chinese medical science, oral ulcer is owing to retention of heat in the spleen and stomach, wind heat are accumulate poison, hyperactivity of deficient fire causes, therefore in the grouping of this medicine, to have clearing away heat to alleviate pain, open all keys, go into the Borneolum Syntheticum of taste warp as monarch drug, and the outstanding consumption that increases the weight of Borneolum Syntheticum, its purpose is to be earlier with the pathogenic fire reducing, is equipped with the Herba Menthae two that has heat clearing away, holds back skin ulcer, stops blooding, goes into the catechu of lung meridian and have dispelling wind and heat pathogens, refresh oneself, throat, goes into lung, Liver Channel again and distinguishes the flavor of medicines as ministerial drug, helps Borneolum Syntheticum pathogenic fire purging heat clearing away, pain relieving; Borax has the drug effect of heat-clearing and toxic substances removing, goes into lung, stomach warp, and it as adjuvant drug, is helped the monarch and his subjects' pathogenic fire reducing, pain relieving, sterilization, with Zhi Qiben; Cortex Phellodendri has the drug effect of heat clearing and damp drying, eliminating fire and detoxication, reducing the asthenic fever, goes into kidney channel, and Indigo Naturalis has the drug effect that the clear speckle of removing heat from blood, heat-clearing and toxic substances removing, moisture absorption are held back skin ulcer, go into Liver Channel, Cortex Phellodendri and Indigo Naturalis as messenger drug, with above-mentioned monarch, minister, adjuvant drug compatibility, are made pathogenic fire purging not impairment of YIN, giving consideration to both the incidental and fundamental.
In order to indicate the effect of Drug therapy oral ulcer of the present invention, selection of clinical year order the 480 routine oral ulcer patients of 1-70, be divided into two groups at random, wherein 320 examples are organized in treatment, matched group 160 examples, in the treatment group, male's 220 examples, women's 100 examples, in matched group, male's 120 examples, women's 40 examples, the treatment situation is as follows:
1, medication and dosage: treatment group medicine of the present invention, directly blow in the affected part or with cotton rod and be applied to the affected part, cover the trouble face with medicine and be as the criterion, three times on the one, wherein medication at night, best results; Matched group is selected GUILIN XIGUA SHUANG for use, blows or is coated with the affected part, and one for several times, each an amount of; Two groups of equal three days courses of treatment, during the other medicines of all stopping using.
2, observation item:
(1) curative effect index: observe the long-pending heat of internal organs, white beads, fire-toxin and the improvement situation sent out;
(2) safety indexes: carry out the inspection of routine blood test, routine urinalysis and liver function and have no adverse reaction.
3, efficacy assessment standard:
(1) produce effects: symptom is obviously improved or is disappeared;
(2) effective: symptom has bigger improvement;
(3) invalid: symptom does not have improvement.
4, efficacy analysis:
By following table as can be known, the treatment group is used medicine of the present invention, and obvious effective rate, the total effective rate of the oral ulcer that the long-pending heat of internal organs, white beads and fire-toxin are sent out are better than using the matched group of GUILIN XIGUA SHUANG.
480 routine patient's symptoms and therapeutic effect tables (n=example)
Symptom Group Produce effects n% Effective n% Invalid n% Total effectively n% The P value
Internal organs Test group 134 ?70 ??58 ?30 ???0 ?0 ??192 ??100
??n=192 ??P<0.05
Long-pending heat Matched group ????7 ?10 ????23 ?33 ??40 51 ??30 ??43
?n=70
White Test group ??168 ?80 ????68 ?20 ???0 ?0 ??236 ??100
??n=236 ??P<0.05
Beads Matched group ????10 ????9 ????34 ?31 ??66 60 ??44 ??40
?n=110
Fire-toxin Test group ???101 ???35 ????194 ?65 ????0 ?0 ??295 ??100
??n=295 ??P<0.05
And send out Matched group ????13 ???11 ?????38 ?32 ???69 ?57 ???51 ???43
?n=108
5, poison is paid effect and untoward reaction:
Test group 320 examples are routine examination blood, urine, liver function before and after medication, and are all no abnormal, and clinical other poison of also not finding are paid effect and untoward reaction.
Confirm by above-mentioned clinical data, Drug therapy oral ulcer of the present invention, total effective rate reaches more than 95%, and is evident in efficacy, and do not have any poison and pay effect.
Embodiment
A, elder generation are respectively with catechu, Herba Menthae, Borax and Cortex Phellodendri roguing, and in the environment of shady and cool ventilation, carry out dried, pulverize separately becomes the fine powder of granularity more than 80 orders then, parts by weight according to catechu 10, Herba Menthae 10, Borax 10, Cortex Phellodendri 10, get this four kinds of fine powders, behind the mix homogeneously, produce mixing fine powders, under 100 ℃ temperature, with mixing fine powders sterilization treatment 30 minutes; B, Borneolum Syntheticum, Indigo Naturalis are ground into the fine powder of granularity more than 80 orders respectively, again under-10 ℃ temperature, respectively with this two kinds of fine powder sterilization treatment 45 minutes;
C, according to the parts by weight of Borneolum Syntheticum 50, Indigo Naturalis 10, the Borneolum Syntheticum fine powder of the sterilization treatment of learning from else's experience and Indigo Naturalis fine powder, the mixing fine powders mix homogeneously with after sterilization treatment makes medicine of the present invention, is stored in dry ventilating and cooling place.

Claims (3)

1, a kind of medicine for the treatment of oral ulcer is characterized in that being become by the following components by weight parts numeral system:
Borneolum Syntheticum 50-60 catechu 10-20
Herba Menthae 10-15 Borax 10-20
Cortex Phellodendri 10-25 Indigo Naturalis 10-15.
2, the medicine of treatment oral ulcer according to claim 1 is characterized in that the preferred weight umber scope of each component is:
Borneolum Syntheticum 50-55 catechu 10-18
Herba Menthae 10-12 Borax 10-15
Cortex Phellodendri 10-20 Indigo Naturalis 10-12.
3, the medicine of treatment oral ulcer according to claim 1 is characterized in that the optimum weight umber of each component is:
Borneolum Syntheticum 50 catechu 10
Herba Menthae 10 Boraxs 10
Cortex Phellodendri 10 Indigo Naturaliss 10.
CN00111204A 2000-07-11 2000-07-11 Medicine for curing stomatocase Expired - Fee Related CN1119159C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00111204A CN1119159C (en) 2000-07-11 2000-07-11 Medicine for curing stomatocase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00111204A CN1119159C (en) 2000-07-11 2000-07-11 Medicine for curing stomatocase

Publications (2)

Publication Number Publication Date
CN1279975A true CN1279975A (en) 2001-01-17
CN1119159C CN1119159C (en) 2003-08-27

Family

ID=4581136

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00111204A Expired - Fee Related CN1119159C (en) 2000-07-11 2000-07-11 Medicine for curing stomatocase

Country Status (1)

Country Link
CN (1) CN1119159C (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384448C (en) * 2004-08-16 2008-04-30 栾继习 Aphtha treating Chinese medicinal preparation
CN100455305C (en) * 2004-08-11 2009-01-28 卢振秋 Externally applied powder
CN101185694B (en) * 2007-12-11 2011-10-26 叶福兰 Powder agent medicine for treating infantile thrush
CN102319343A (en) * 2011-09-13 2012-01-18 徐柔云 External cream used for treating toothache caused by inflammations
CN102423388A (en) * 2011-11-08 2012-04-25 上海市浦东新区北蔡社区卫生服务中心 Traditional Chinese medicine composition for oral ulcer
CN103720866A (en) * 2013-12-27 2014-04-16 廖勇 Traditional Chinese medicinal composition for treating dental ulcer and preparation method thereof
CN103768218A (en) * 2012-10-23 2014-05-07 徐中喜 Traditional Chinese medicine composition for treating aphtha and preparation method thereof
CN107184865A (en) * 2017-05-31 2017-09-22 皖南医学院 It is a kind of to treat medicine of canker sore and preparation method thereof
CN107334896A (en) * 2017-06-14 2017-11-10 广西壮族自治区疾病预防控制中心 A kind of pharmaceutical composition for treating canker sore disease
CN109432322A (en) * 2018-12-24 2019-03-08 四川芝林宜健生物科技有限公司 A kind of Chinese medicine composition and preparation method thereof preventing and treating canker sore
CN112237592A (en) * 2020-11-30 2021-01-19 赵俊 Oral ulcer secret recipe medicine

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101444555B (en) * 2008-11-08 2011-06-01 青岛市市立医院 Purely Chinese traditional medical film for curing oral ulcer and method for preparing same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077382A (en) * 1993-01-12 1993-10-20 姜定齐 The Chinese patent medicine of treatment oral ulcer
CN1067273C (en) * 1994-05-27 2001-06-20 杨更生 Pearl oropharyngeal powder
CN1129132A (en) * 1995-12-14 1996-08-21 王利亚 Ulceromembrane of Chinese medicine and production technology thereof

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100455305C (en) * 2004-08-11 2009-01-28 卢振秋 Externally applied powder
CN100384448C (en) * 2004-08-16 2008-04-30 栾继习 Aphtha treating Chinese medicinal preparation
CN101185694B (en) * 2007-12-11 2011-10-26 叶福兰 Powder agent medicine for treating infantile thrush
CN102319343A (en) * 2011-09-13 2012-01-18 徐柔云 External cream used for treating toothache caused by inflammations
CN102423388A (en) * 2011-11-08 2012-04-25 上海市浦东新区北蔡社区卫生服务中心 Traditional Chinese medicine composition for oral ulcer
CN103768218A (en) * 2012-10-23 2014-05-07 徐中喜 Traditional Chinese medicine composition for treating aphtha and preparation method thereof
CN103768218B (en) * 2012-10-23 2016-06-29 徐中喜 A kind of Chinese medicine composition treating aphtha and preparation method thereof
CN103720866A (en) * 2013-12-27 2014-04-16 廖勇 Traditional Chinese medicinal composition for treating dental ulcer and preparation method thereof
CN107184865A (en) * 2017-05-31 2017-09-22 皖南医学院 It is a kind of to treat medicine of canker sore and preparation method thereof
CN107334896A (en) * 2017-06-14 2017-11-10 广西壮族自治区疾病预防控制中心 A kind of pharmaceutical composition for treating canker sore disease
CN109432322A (en) * 2018-12-24 2019-03-08 四川芝林宜健生物科技有限公司 A kind of Chinese medicine composition and preparation method thereof preventing and treating canker sore
CN112237592A (en) * 2020-11-30 2021-01-19 赵俊 Oral ulcer secret recipe medicine

Also Published As

Publication number Publication date
CN1119159C (en) 2003-08-27

Similar Documents

Publication Publication Date Title
CN1119159C (en) Medicine for curing stomatocase
CN101129578A (en) Frankincense bedsore powder
CN104940627A (en) Traditional Chinese medicine composition for promoting wound healing, and preparation method of traditional Chinese medicine composition
CN100386106C (en) Medicine for treating acne and its preparation
CN103142737B (en) Traditional Chinese medicine capsule for treating fracture Qi-stagnation and blood stasis and preparation method thereof
CN107982387A (en) A kind of Chinese medicine composition for treating scald and preparation method thereof
CN103751342B (en) A kind of medicine with heat-clearing and toxic substances removing, reducing swelling and alleviating pain function
CN1180833C (en) Chinese medicine against skin and external diseases
CN103272028B (en) A kind of medicine for the treatment of traumatic injury and rheumatic arthralgia
CN105998840A (en) External use ointment used for treating insect bite dermatitis and preparation method
CN112353902A (en) Throat medicine blowing and tissue regeneration promoting powder and preparation method and application thereof
CN1132587C (en) Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
CN1167455C (en) Medicine for treating acne and its preparing process
CN105362830A (en) Traditional Chinese medicine preparation for treating gum bleeding and preparation method thereof
CN111249432A (en) Traditional Chinese medicine for preventing and treating pneumonia and lung cancer and preparation method thereof
CN1843492A (en) Traditional Chinese medicine preparation for treating mammary gland hyperplasia
CN104173480A (en) Traditional Chinese medicine composition for treating infantile suppurative tonsillitis
CN1279953C (en) Mediciation for curing female disease
CN101983681A (en) Medicament for treating abnormal leucorrhea
CN103157053A (en) Pain-relieving traditional Chinese medicine preparation and preparation method thereof
CN1745839A (en) Compound Chinese medicine for gout
CN111569023A (en) A composition for treating gynecological diseases and preventing and treating HPV
CN1199635A (en) Cough and asthma curing plaster stuck to acupoint
CN105998968A (en) Medicine composition for treating damp-heat type vulvitis
CN113521158A (en) A topical Chinese medicinal composition for treating wound ulcer, pyocutaneous disease, trauma and dermatoses

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Wengong

Document name: payment instructions

C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Liu Wengong

Document name: Notification of Termination of Patent Right

C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee